Related Experiment Video
Updated: Aug 24, 2026

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
Published on: February 15, 2018
Epidermal growth factor and necrotizing enterocolitis
1Department of Pediatrics and Steele Memorial Children's Research Center, University of Arizona, 1501 N. Campbell Ave, P.O. Box 245073, Tucson, AZ 85724, USA. dvorakb@peds.arizona.edu
Abstract:
As the number of extremely low-birth-weight infants increases,necrotizing enterocolitis remains a critical eminent problem. Supplementation of enteral feeds with biologically active substances normally present in breast milk, such as epidermal growth factor, seems to be a logical and safe way to reduce the incidence of intestinal inflammation and necrotizing enterocolitis. Continuing basic research and clinical studies are essential before epidermal growth factor can be introduced as an efficient therapeutic approach in the treatment of neonatal necrotizing enterocolitis.
Related Concept Videos
Mitogens and the Cell Cycle
Bacterial Gastroenteritis
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Regulation of Angiogenesis and Blood Supply
Clinical Applications of Epidermal Stem Cells
Cellular Injury IV: Necrosis

